ID: ALA3828345

Max Phase: Preclinical

Molecular Formula: C21H13NO4

Molecular Weight: 343.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccccc1C(=O)Nc1ccc2c(c1)C(=O)c1ccccc1-2

Standard InChI:  InChI=1S/C21H13NO4/c23-19-15-6-2-1-5-13(15)14-10-9-12(11-18(14)19)22-20(24)16-7-3-4-8-17(16)21(25)26/h1-11H,(H,22,24)(H,25,26)

Standard InChI Key:  AFLSVPDXCXLNDA-UHFFFAOYSA-N

Associated Targets(non-human)

Botulinum neurotoxin type E 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.34Molecular Weight (Monoisotopic): 343.0845AlogP: 3.85#Rotatable Bonds: 3
Polar Surface Area: 83.47Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.91CX Basic pKa: CX LogP: 3.86CX LogD: 0.37
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.59Np Likeness Score: -0.58

References

1. Kumar G, Agarwal R, Swaminathan S..  (2016)  Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model.,  24  (18): [PMID:27353886] [10.1016/j.bmc.2016.06.036]

Source